A cost-utility analysis of alternative drug regimens for newly diagnosed severe lupus nephritis patients in Thailand

Abstract

In the Thai context, the combination of i.v. CYC for the induction phase followed by AZA for the maintenance phase should be considered as the first-line therapy for newly diagnosed severe LN, as it seems to be the most cost-saving regimen.